PubRank

Sikander Ailawadhi

Author PubWeight™ 12.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. J Support Oncol 2007 2.70
2 Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol 2006 2.61
3 Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1. Leuk Lymphoma 2012 1.50
4 Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial. Leuk Lymphoma 2009 0.87
5 Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells. Br J Haematol 2015 0.85
6 Localized LECT2 amyloidosis of the adrenal gland with coexisting MGUS: a diagnostic challenge. Ann Hematol 2015 0.80
7 A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients. Br J Haematol 2011 0.79
8 Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner. Br J Haematol 2011 0.78
9 Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma. Clin Nucl Med 2016 0.76
10 Vascular endothelial growth factor polymorphisms in early-stage non-small-cell lung cancer. J Clin Oncol 2008 0.75
11 HLA-identical sibling stem-cell transplantation in first-remission AML. Blood 2007 0.75
12 Multiple asymptomatic colon plasmacytomas: a diagnostic and therapeutic dilemma. Ann Hematol 2014 0.75
13 Disseminated histoplasmosis in a renal transplant patient. Int J Hematol 2014 0.75
14 Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma. Oncology 2014 0.75
15 Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion. Chemotherapy 2017 0.75